TABLE 3.
Parameter | NC (n = 17) | PE (n = 17) |
Lipoprotein concentrations (mmol/l)a | ||
Maternal TC | 5.6 ± 2.2 | 6.4 ± 1.1 |
Fetal TC | 2.6 ± 1.5b | 1.7 ± 0.3b |
Maternal TGs | 2.2 ± 0.7 | 2.6 ± 0.6 |
Fetal TGs | 1.1 ± 0.9b | 0.7 ± 0.9b |
Maternal HDL | 1.5 ± 0.3 | 1.4 ± 0.9 |
Fetal HDL | 0.9 ± 0.4b | 0.6 ± 0.1b |
Maternal LDL | 3.5 ± 1.9 | 3.8 ± 0.1 |
Fetal LDL | 1.2 ± 0.8b | 0.8 ± 0.3b |
apoA1 and apoE concentrations (g/l) | ||
Maternal apoA1 | 19.3 ± 9.3 | 23.6 ± 7.4 |
Fetal apoA1 | 2.4 ± 0.9b | 2.8 ± 1.4b |
Maternal apoE | 0.6 ± 0.4 | 1.0 ± 0.5c |
Fetal apoE | 0.4 ± 0.1 | 0.5 ± 0.1b,c |
Data represented as mean ± SD. NC, normotensive control; PE, preeclampsia; OHC, hydroxycholesterol.
Lipoprotein concentrations previously measured (21).
P < 0.05 between maternal and fetal samples.
P < 0.05 between normotensive controls and women with preeclampsia.